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I. ABSTRACT OF RESEARCH ACCOMPLISIMENTS
During the contract period of January 7, 1970 through October 31, 1970,
clinical pathology procedures for the detection of diseases in germfree
mice maintained within Class III isolators were further developed and
tested. The information obtained was supplied in detailed monthly
Progress Reports to NASA.
In transmission experiments, murine hepatitis virus (MHV3) has been shown
to infect CD-1 mice (previously not demonstrated in this strain). At 2
to 4 days postinoculation the spleen weights were reduced and had lympho-
cytic karyorrhexis in the thymus-dependent area of splenic follicles.
The germinal center assay was found to be  superior indicator of immuno-
logic stimulation as opposed to the classic complement fixation pro-
cedures. At 6 to 8 days postinoculation, concomitant with an increase
in spleen weight, the germinal centers were near maximum in size and
number. Complement fixation titers revealed antibody to M1?V3 at 16 to 32
days postinoculation. Like the lactic dehydrogenase virus (LDV),* MHV3
inhibits cellular immunity as measured by skin graft rejection. In both
LDV and MHV3, the loss of cellular immunity was associated with lympho-
cytic karyorrhexis of the mobile population of small lymphocytes. An
assay method has been developed for :fHV3 using LDH levels as an indicator
of infection rather than histologic examination.
Macrophage cultures will support MHV3 irrespective of the age of macro-	 +'
phage donor mice.
Thymosin, which induces a heightened germinal center response, shows no
detectable histologic alteration in the thymus-dependent area of the
splenic follicle even though it has been shown to accelerate graft
rejection (enhanced cellular immunity).
LDV has been passaged and used as another test system for enzyme assays.
LDV causes an increase in LDH at 2 days postinoculation which is main-
tained throughout the life of the infected mouse. LDV inoculates show a
marked increase in spleen weight at 16 days postinoculation.
Plasmodium berehei (the agent of murine malaria)—* has been passaged in
both mice and hamsters. In mice, P. berehei results in a decrease in body
weight, and a concurrent absolute decrease in liver and kidney weights,
while spleen weights become increased by 8 days postinoculation. There
is a moderate increase in serum LDH at 4 hours postinoculation, which
*Dr. A. L. Notkins, National Institute of Dental Health, N.I.H.
r
**Dr. S. Criswell, NASA, .iC, Houston, Texas
*_
2.
_	 4
1
returns to normal before showing; a severe increase by 6 days postinocu-
lation. In hamsters, althouZh the body weight remained constant, there
was a 6-fold increase in spleen weights by 8 days postinoculation.
Serum LDII levels were moderately increased at 5 days postinoculation.
There was a 15 to 25% decrease in hematocrit by 8 days postinoculation
which paralleled the number of parasitized red blood cells. In
parasitized mice, the increase in LD11 values corresponded to increased
hematopoiesis in spleens. Similarly, in hamsters the amount of hemato-
poiesis in spleens was relatively low as was the response in serum LD11,
indicating the origin in mice may be related to increased activity
rather than cellular destruction.
Design and construction of an aerosolization chamber for the study of
titanium-containing dusts has been completed. Standard curves have been
obtained spectrophotometrically with Ti0 2 . Titanium has been detected
in the 1}mphoid structures of hamsters, mice, and rats. In a prototype
chamber, rats were treated with aerosolized Ti02 and distribution of
titanium established.
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II. LIST OF MANUSCRIPTS AND PUBLICATIONS SUPPORTED IN PART BY
CONTRACT NAS 9-8918
A. Adams, M. L., Kenyon, A. J., Jones, N. D., Schmidt, N. F., and
Kim, S. N. Lymphoproliferative diseases of fowl - LD11 isozymes
associated with lymphoblastic leukemia (JM-V). J. Natl. Cancer
Inst. 46: 43 -48, 1971.
B. Olmsted, J., and Kenyon, A.. J. Lymphoproliferative diseases of
fowl - Radiologic evidence of transplantable nature of ivian
lymphoblastic leukemia (M-V). Submitted to Avian Diseases.
C. Kenyon, A. J., Smith, G. V., Kim, S. N., and Fredrickson, T. N.
Depressed cellular immunity and alterations of thymus-dependent
areas associated with virus replication in macrophages. Submitted
to Nature.
D. Olmsted, J., and Kenyon, A. J. Lymphoproliferative diseases of
fowl - Lymphoblastic leukemia (JM-V) as a radiologic model.
Submitted to Acta Radiologica.
E. Kenyon, A. J., and Jones, N. D. Dysproteinemia of Coturnix quail
associated with ova reabsorption. For submission to Avian Diseases.
F: Kenyon, A. J., Olsted, J., Fredrickson, T. N., and Jones, N. D.
Correlation of germinal center response with development of lesions
in gnotobiotic mice inoculated with murine hepatitis virus. For
submission to the American Journal of Veterinary Research.
G. t.dams, M. L., Kenyon, A. J., Olsted, J., LaDoux, R., and Jones, N. D.
Early detection of murine malaria (Plasmodium berehei) by LDH iso-
zymes. For submission to the American Journal of Veterinary Research.
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III. PARTICIPANTS
A. Principal Investigator
5.
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IV. BUDGET DESCRIPTION
Detailed budget report will be prepared by the Office of Research
Accountant,
	 Mr.	 H.	 Dest,	 University of Connecticut, Storrs and
submitted seperately.
A. Salaries and Wages
1.	 A.	 J.	 Kenyon,	 Principal
	
Investigator
10% Academic Year (9 months) None
2.	 S. N. Kim,
	 Co-Principal
	
Investigator
10% Academic Year (9 months) None
3.	 Mary Adams,
	 Research Assistant II
100% Academic Year (12 months) $7200
4.	 Graduate Assistant 	 (M.S.,	 12 months) 4000
5.	 Student Labor @ $2.00/hour 2000
TOTAL SALARIES AND WAGES $13,200
B. Applicable Fringe Benefits @ 8% 1,056
1	 C. Indirect Costs (53% of Salaries and 'cages) 6,996
'	 D. Supplies 2,340
1.	 Reagents
a.	 immunological	 $200
b.	 enzyme substrates	 200
c.	 chemicals	 200
d.	 isotopes,	 immuno-tests	 250
2.	 Animals
a.	 mice (CD-1), 200 germfree @ $4.00 each $800
b.	 feed (germfree) Model 25 shipper and
25 lb.	 feed $50 100
c.	 mice (CD-1), 200 conventional @ 45¢ each 90
d.	 quail eggs, 400 @ 25¢ each 100
e.	 quail chicks,	 100 @ 4.00 each 400
E. Equipment 2,500
• 1.	 Electronic components for modification of
' existing electrophoretic equipment $500
2.	 Incidental equipment of cell fractionations 200
-	 - 3.	 Isolators:
Germfree Associates (rigid)	 1,000
- Smyder (flexible film,	 2 @ $400 each) 800
6.
F. Travel
1. Three trips to MSC/NASA
2, Transportation to pick up
supplies and animals
G. Other
1. Publications Costs
$1,000
$750
250
200
TOTAL REQUESTED
	 $27,292
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V. DETAILED REPORT
A. Overall Objeckives
The object?ves as described here represent an organizational
modification of the STATEMENT OF WORK (See Appendix I for details).
1. Develop and test procedures for biochemical interpretation of
disease.
2. Gain base-line information on the immunolgoc responsiveness of
CD-1 germfree mice (Charles River Breeding Laboratory).
3. Evaluate the germinal center assay for detection of antigenic
agents by infecting CD-1 mice with known •v iruses and protozoan
organisms.
4. Evaluate thymosin for its ability to heighten germinal center
response to standard antigens.
B. Research Accomplishments
1. Studies on MHV3 as a Test System for Procedures Used in Class III
Cabinetry.
The murine agent M1iV3
 was selected as one of a series of test
agents because in mature mice it induces only a transient disease
with extremely low mortality, yet the disease may be easily
monitored by procedures described in the test protocol for sample
analyses (enzyme assay; lactic dehydrogenase [LD111). The M1iV3
agent has been passed several times in CD-1 mice (COBS) since
originally obtained from Dr. T. N. Fredrickson, Department of
Animal Diseases, University of Connecticut. The original passage
was from 7-day-old BALB/c pups. The infectivity of the inocuium
has been greatly increased by harvesting livers of 10- to 14-day-
old CD-1 pups on the 4th to 5th day postinoculation rather than
waiting until massive liver lesions occur, as is commonly done.
To determine the peak infectivity (maximum yield of agent), pups
10 to 14 days old, were inoculated at killed at 4 and 6 days post-
inoculation. In addition to harvesting tissue, blood was obtained
for serum LDH assay. Tile release of LDH appeared to correlate
well with progressive destruction of macrophages and hepatocytes.
When necrotic foci were apparent on gross postmortem, the enzyme
levels were declining to normal values which indicates that
destruction of cells had already occurred and that repair processes
were taking place. Figure 1 diagramatically shows the relation-
ship of events associated with M11V3
 infection.
a. Histologic evaluation
In each of the transmission experiments, 24- to 18-day-old
germfree CD-1 mice were housed in Snyder flexible film
isolators. From 48 to 96 hours postinoculation, M11V 3
 inoculates
1
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developed larf;e areas of necrosis (15-nphocytic karyorrhexis)
in the "thymus-dependent areas" of splenic follicles. In
many follicles the cellularity surroundin- the central
arteriole was totally obliterated. In addition to the focal
necrosis observed in livers of P111V3 infected mice, death of
macrophages and lymphocytes in the "thymus-dependent area"
of splenic lymphoid follicles was a consistent observation
at 48 hours postinoculation. This lesion is less evident at
4 days postinoculation and is not apparent at 8 days post-
inoculation (Table 1).
Figure 2 shows the nature of lesions seen in spleens of mice
inoculated with LDV, PflIV3 , and the MiIV3 agent in combination
with the Aleutian disease virus.
b. Spleen weight increase
A consistent finding was that the spleens of MIIV 3 inoculates
either dropped in weight or remained unchanged during the
first 4 days postinoculation. After this depression in
weight, the 1f"3 inoculates developed a rapid increase in
spleen weight (200-240 mg.) at day 8 postinoculation. This
increase in weight appeared to be dice to an increase of
inflzmmatory cells in the splenic red pulp (Figure 3).
c. LDIi increase
,a
Because MHV3 may not produce death in test mice, a test
6ystem was devised whereby 10-day-old CD-1 pups were used as
an assay subject with infection being established on the
basis of elevated LDH levels at 6 days postinoculation. This
procedure was more sensitive than histologic analyses and
much less time consuming and costly (Figure 4).
d. Complement fixation
Complement-fixing antibodies were sought by titration to
M1"3
 by Microbiological Associates, Bethesda, Maryland.
Levels of antibody were detectable at 16 to 32 days post-
inoculation, but it was apparent that the germinal center
assay was a better indicator of immunologic stimulation since
it preceded detectable serum antibod y 1Rsvels by at least 10
days.
e. Craft rejection
The effect of M1IV3 infection on cellular immunity was
`	 determined using skin allograft re f ection. Standard, full-
thickness, skin grafts were made from C57BL/6 male donors to
21-day-old CD-1 male recipients. There was a delay in graft
rejection of 2 to 3 days in MIIV3 infected mice. Since the
thymus-dependent area of the spleen is associated with
cellular immunity, the inhibition of immune response may be
the result of the destruction of cells in the "thymus-dependent
area" of the spleen. Similar damage induced by release of
9.
proteolytic enzymes from macrop'ages may account for
destruction of hepatocytes and also contribute to altered
immunity. Figure 5 shows the gross appearance of skin
giafts on infected and no rnial mice.
f. Peritoneal macrophage culture
Macrophage cultures were established to test for and main-
tain PIHV3 passage inocula. Murine macrophages were obtained
by repeated intraperitoneal inoculations of tetanus toxoid.
peritoneal exudate cells were washed out with medium 199.
Estimates of cell populations are made by cell counting on
a hemocytometer. Cells were then placed in Leighton tubes,
gassed, and incubated. After 72 hours incubation the
macrophages are usually well differentiated and ready for
inoculation with a 1:10 dilution of 10% liver homogenate from
MHV3
 infected mice. The inoculated cultures were incubated
for 48 hours. The susceptibility of different stains of
mouse macrophages was as follows: LAF 	 A/HE	 C57BL/6 as
determined by morphologic changes and cell death at approxi-
mately 12-hour intervals from time of inoculation. At 48
house postinoculation the degree of destruction was so
advanced, no detectable difference between cell populations
was obtainable.
2. Studies or Thymosin for Immunologic Enhancement
Thymosin prepared from fetal calf thymus induces a heightened
germinal center response to heterologous erythrocytes used as
antigens. A calf kidney extract compared on an equal weight
basis induced very little germinal center response.
The experiments performed with thymosin show the consistent
effect it has on reducing the rejection time of allografts made
from C57BL/6 to CD-1 recipients. The effect of MHV 3
 in delaying
rejection is an equally consistent factor. See Figure 7 for
graft rejection rates of mice administered thymosin and infected
with MHV3.
Although as anticipated, the main effect of thymosin is not on
germinal center formation but rather is on the mobilization of
small lymphocytes in the thymus-dependent areas of splenic
follicles. However, there was indeed an increased rate of
germinal center formation in stimulated mice.
3. LDV as a Test System for Class III Cabinetry
=	 The LDV agent was administered by the intraperitoneal route to
16 germfree 23-day-old CD-1 mice, to be killed at 2, 4, 8, and
16 days postinoculation. Organ weights were recorded. Serum was
obtained for LDH assay and tissues were obtained for histologic
observation.
t10.
a. Spleen weight increase
At 2 and 4 days postinoculation spleen weights of control
animals were greater for uninoculated controls, however, by
day 8, LDV inoculates showed a marked increase which was
maintained to day 16 (Figure 8).
b. LDH increase
LDV inoculates showed a 2-fold increase in LDII at 2 days
postinoculation, and a 3-fold increase by 4 days. In some
instances, a transient dro; occurred at 8 days with levels
increased 3 to 4-fold again by 16 days postinoculation.
The range of LDH values as spectrophotometric units was
from 3,800 to 10,000 during the course of disease. Mice
infected with LDV never return to normal serum levels
throughout their life (Figure 9).
c. Histologic evaluation
The only detectable histologic lesion in LDV infected mice
occurs at 48 hours postinoculation. This lesion is lympho-
cytic karyorrhexis of the thymus dependent area of splenic
follicles. Similar lesions are seen in mice inoculated
with M1IV3
 and the lymphocytic choriomengitis virus. It is
tempting to speculate that virus replication in macrophages
results in release of proteolytic enzymes causing destruction
of associated cellular structures. See Figure 2 for a
comparison of lesions of LDV and I'IIV3.
4. Studies with Protozoan Agents ( Plasmodium berQhei)
To extend the spectrum of agents previously used as test systems
to evaluate the analytical procedures conducted on mice in
Class III cabinetry, murine malaria was selected as a protozoan
agent capable of causing an acute.response.
Plasmodium berghei has been serially passaged 18 times during
the course of this study. The original inocula was passed 3
times in mice before transmission to hamsters. Ten passes were
made in hamsters prior to the disease being passed back into
mice and carried 5 passages. In each case, parasitized red
blood cells were obtained by bleeding from the supra-orbital
plexus. Per cent parasitized cells were estimated, in each case,
by observations made on blood smears stained with Wright-Ciemsa
(Figure 10).
a. Mouse experiments
Mice inoculated with Plasmodium berghei show a decrease in
body weight, and an absolute decrease in liver and kidney
weights which is in accord with the decrease in body weights.
The spleen weights of inoculates, however, show an absolute
increase which was evident as early as 4 days postinoculation
(Figure 11).
*- - .
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Serum LD11 levels of Plasmodium bernhei inoculated mice show
a rapid .increase to 6,000 units at 4 hours postinoculation
as an early response. A marked increase to 27,000 units
occurred at 6 days postinoculation as a late response
(Figure 12).
Early in the course of the disease (2 days postinoculation)
the principal splenic lesion may be related to the large
number of histiocytes in the red and white pulp. As the
disease progresses, evidence of increased hematopoiesis is
apparent. By 4 clays postinoculation hemosiderin deposits
are apparent throughout the liver parenchyma. From this
point, the main lesion consists of hyperplasia of the red
pulp and progresses to such an extent that it destroys the
normal splenic architecture.
b. Hamster experiments
Hamsters inoculated with Plasmodium berphei show no decrease
/	 in body weight, but do exhibit a 6-fold increase in spleen
weights_which is detectable 4 days postinoculation (Figure
13).
Plasmodium berghei hamsters show only a moderate increase
in serum LDII activity to 5,000 units at 5 days postinoculation
(Figure 14).
The distribution of lesions in hamsters includes inflammatory
cells in liver and kidney as perivascular cuffs (at 8 days
postinoculation). Although the liver contains considerable
hemosiderin, the spleen does not have the tremendous hyper-
plasia of the red pulp as is seen in mice. The bone marrow
of inoculated hamsters consisted mainly of blast forms with
many cells in mitosis.
As in mice, hamsters inoculated with Plasmodium ber 'ghei show
a marked increase in per cent parasitized red blood cells to
almost 100% at 6 days postinoculation (Figure 15). As may
be expected, the hematocrit decreases from 50% to 25% at 8
days postinoculation (Figure 16).
5. Preliminary Studies on the Biologic Effects of Inhaled Lunar Dust
a. Aerosolization chamber
Construction of a chamber for the housing of germfree or
conventional animals to be used in inhalation studies with
simulated lunar dust, titanium and silicon dioxides, has
been completed (working drawings to be submitted in future
reports).
b. Stud; s with titanium dioxide: standard curves
The procedure of Huggins and Froehlick (J. Exptl. Med. 124:
1099, 1966) has been modified and applied to titanium dioxide,
obtained from Dupont as Ti-pure R-900, to yield linear curves
0.
1,
12.
with a range of 10 to 1,000 ug. This procedure has been
applied to detection of Ti0 2 from lymphoid structures of
hamsters.
c. Experimental results
In a modified aerosolization chamber, 23-day-old male rats
were exposed to aerosolized titanium dioxide. Animals were
killed at 6, 12, and 24 hours postinoculation. Another 3
animals were inoculated intravenously (tail vein) with
0.8 ml. of 250 mg. TiO 2 /ml. saline. Histologic evaluation
of tissues revealed titanium dioxide in alveolar macrophages
and as time progressed in the peripheral zone of splenic
follicles (Figure 5).
13.
VI: APPENDIX
A. Statement of Work
1. Purpose
To obtain workable methods for testing biologic activity of
lunar soil in and on homoiothermic subhuman animals. In
order to do this, the techniques must be capable of differ-
entiating physical (toxic) activity from biologic (antigenic)
activity.
2. Objectives, General
a. Develop standard operating procedures (SOP's) for toxico-
logic and immunologic techniques.
b. Verify these techni ques with known toxic and immunogenic
material.
c. Supply results and interpretation of these tests.
3. Objectives, Specific
a. Although the techniques may be worked out on any mice or
quail, the SOP's and results must be directly applicable
1 to those strains used by the Lunar Receiving Laboratory
(LRL). The animals used are germfree and conventional
random-bred Charles River CD-1-; strain of mice and the
Coturnix coturni;c Japonica strain of quail.
b. The SOP's and results for the mice must take precedence
although the work may proceed concurrently with both species.
c. All SOP's must take into consideration the constraints of
of Sample Laboratory of the LAL, i.e., space, personnel,
and Class III quarantine cabinetry.
d. Evidence of antigenic stimulation will be sought by
evaluation of host reaction in lymphoid structures in response
to soluble antigens.
e. Response to particulate antigens (lunar or simulated lunar
material) by a number of antigen-antibody reactions will be
tested.
f. Infectivity following confirmed antigenic response will be
obtained by quantitative estimates of response in successive
passages of the material.
g. Immunochemical and electrophoretic methods will be used to
show evidence of dysproteinemias of clinical significance to
the various biologic and nonbiologic materials.
*The Charles River Breeding Laboratories, Inc., Wilmington, Mass. 01887.
14.
B. Work Plan for Future Studies
1. The contractor shall initiate a pilot program to determine the
immunologic, physiologic, and morphologic changes induced with
aerosolized simulated lunar dusts.
2. The quantitative distribution of dust shall be determined in
lymphoid and other tissues of mice and ferrets given dust by
different modes (insufflation, inhalation, intravenously, and
intraperitoneally).
3. The effect of macrophage depletion with titanium and dilicon
dioxides and SLD shall be determined initially in relation to
several infectious agents which produce either an acute or
chronic disease.
4. The acute response shall be determined in ferrets aerosolized
with SLD and challenged with aerosolized influenza virus
(influenza A PRO. These experiments shall be constructed to
yield an index of pathogenicity or disease enhancement as a
l	 function of dust exposure.
5. The effect of Ti02, S102, and SLD on chronic or slow disease
processes shall be determined in ferrets aerosolized with the
Aleutian disease virus. The experimental design shall be
constructed to relate dust exposure to time required for primary
onset of lesions.
6. Mice (DBA2) shall be aerosolized with SLD and Ti02 to determine
the enhancement of latent leukemogenic viruses. Experiments
shall be constructed to determine the effect dust has on induc-
tion of parenteral and inhalation leukemogenesis and on the
reaction of peripheral and central lymphoid organs in response
to virus (Friend virus) induced lymphoproliferation.
7. Determine the effect specific metals or metal complexes (analogous
to lunar dust) have on germinal center formation and deposition
in lymphoid tissue.
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Figure 2,
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This figure demonstrates the nature of the lesions seen at
48 hours postinoculation with LDV (top), MHV3
 (center), and
HHV3 and Aleutian disease virus (bottom). In the case of
LDV and MHV3 , the area of lymphocytic ' karyorrhexis was re-
stricted to the thymus-deFendent lymphocytes adjacent to
the central arterioles. When the Aleutian disease virus is
given simultaneously with KHV3, histiocytic activity is
apparent in the peripheral zones of the splenic follicles.
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Figure 5.
L
Photographs taken at 8 days after transplantation of skin from C57/BL
donors to CD-1 recipients. The mouse in the upper photograph was in-
fected with the MI!V3 virus and, as may be seen, its graft appears
her:lthy. The mouse in the lower photograph is an uninoculated control
and its graft is in an advanced state of rejection..
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Figure 6.
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This photograph depicts the rate of rejection
of WIV3
 infected mice with skin grafts.
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This photograph demonstrates the extensive parasitemia
that existed in mice 5 days postinoculation with
Plasmodium berghei. At this stage the LDH values have
reached a peak and will slowly decrease.
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Figure 11. Plasmodium berr,hei in Mice - Spleen Weights
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FiEure 16. F1asmodiuT berChei in Hamsters
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Figure 17. Titanium Dioxide Aerosolization
is
Top: Lung section taken after 24 hours exposure to
TiO2 aerosol. Note the macrophage containing
dust particles.
Middle: Liver section containing T102 Kupffer cells.
Bottom: A splenic follicle showing migration of Ti02
from the marginal zone toward the peripheral
zone of germinal center fo nnation.
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TABLE 1
Cerminal Center (CC) Response to M11V
Experiment Number	 Day	 Number of dice	 CC Grade	 Average Spleen Weight (mg.)
1.*	 Hiv	 2	 .3	 -	 31
Control-^ 	 2	 2	 -	 25
2.	 MHV	 2	 2	 -	 39
Control*-	 2	 2	 42
1. MHV	 4	 3	 +}t	 42
Control	 4	 2	 +	 30
2. MHV	 4	 2	 44+	 30
Control	 4	 2	 +F	 49
1. MHV	 8	 3	 -i-H+	 50
Control	 8	 2	 ++	 38
2. MHV	 8	 2	 -ff+}	 126
Control	 2	 4+ '	 38
1.	 MHV	 16	 3	 ++++	 45
Control	 16	 2	 +-i+	 33
.2.	 MHV	 16	 .2 ,	 +1-++
	
71	 -
Control	 16	 2	 •f-1-	 65
1. MHV	 32	 3	 ++-f+	 68
Control	 32	 2	 -f-H+	 72
2. ' HHV	 32	 2	 +H-I-	 109
Control	 32	 2	 -H+f	 39
*Experiment No. 1 represented the first test MR V3 from first passage out of
1BALB/c tissue extract. In subsequent experiments, where the infectivity was markedly
increased, the increase in splenic weight at day 8 was apparent.
**These controls represented mice inoculated with liver homogenates of normal
mice. In addition to this control, uninoculated controls were maintained and
examined as above.
